Regencell Bioscience (RGC) has had the highest return since August 31, 2023 by a mid-cap US stock, returning 3,992.6%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 3,992.55% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 3,880% |
Power Solutions International, Inc Common Stock (PSIX) | 2,973.33% |
Dave (DAVE) | 2,810.77% |
GeneDx (WGS) | 2,443.5% |
Sezzle (SEZL) | 2,062.69% |
D-Wave Quantum (QBTS) | 2,035.83% |
Quantum Computing (QUBT) | 1,442.28% |
Soleno Therapeutics (SLNO) | 1,102.4% |
Ondas (ONDS) | 634.67% |
Tutor Perini (TPC) | 617.91% |
Abivax SA American Depositary Shares (ABVX) | 610.34% |
New Gold (NGD) | 593.33% |
Centrus Energy (LEU) | 589.81% |
Argan (AGX) | 587.45% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 563.88% |
Uniqure (QURE) | 529.9% |
American Superconductor (AMSC) | 512.53% |
SoundHound AI (SOUN) | 509.43% |
Nuscale Power (SMR) | 505.12% |
Perpetua Resources (PPTA) | 500.87% |
Cidara Therapeutics (CDTX) | 487.44% |
Scholar Rock (SRRK) | 475.12% |
Verona Pharma PLC ADR (VRNA) | 473.38% |
Innodata (INOD) | 449.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
